Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GCSH pseudogene 3 (GCSHP3) is a non-protein-coding genomic locus related to the Glycine cleavage system protein H (GCSH). Pseudogenes are defined by their resemblance to a parent gene but contain disabling mutations that prevent them from encoding functional proteins. GCSHP3 is not involved in glycine cleavage or metabolic pathways directly, nor does it play a functional role in cell signaling, drug response, or disease. Instead, like other pseudogenes, it may contribute to genomic architecture and occasionally to regulatory phenomena, but its presence can pose challenges for genomic data analysis due to its high sequence similarity to protein-coding genes. There is no evidence it acts as a receptor, enzyme, transporter, or transcription factor, nor is it validated as a clinical biomarker or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GCSH pseudogene 3 (GCSHP3).